|
|
|
NICUniversity.org CE/CME Lecture Details
|
| |
|
| |
|
| |
|
-- back to lectures --
|
| |
| |
| |
| |
| Course Title: |
|
Respiratory Syncytial Virus (RSV): From Pathogenesis to Prevention |
|
|
| |
| |
| |
| |
| |
| | Credit Hours: | 1 | | Valid Until: | 12/31/2010 |
|
| | Lecturer: | Part 1: Andrea Morris
Part 2: Leonard E. Weisman
Part 3: Dianne S. Charsha | | Date Released: | 12/1/2008 |
|
| | Affiliation: | Various | | |
|
| |
View the Post-Test - Login Required
|
|
| |
| |
| |
| | Lecture Overview: |
|
| | Respiratory syncytial virus (RSV) is the most important cause of viral lower respiratory tract illness in infants and children worldwide. It is responsible for over 120,000 annual hospitalizations in infants in the US alone. The disease spectrum includes a wide array of upper and lower respiratory symptoms that can have a significant impact on morbidity and mortality. Additionally, RSV infection can be associated with the development of acute, short-term diseases such as otitis media and chronic, long-term such as reactive airway disease and asthma. The costs of caring for patients who experience severe lower respiratory tract infection and their sequelae are substantial and cut across all segments of the neonatal and pediatric health care sector. Presently, pharmacological management of this disease in limited to symptomatic therapy, anti-viral therapy, and monoclonal antibody preventive therapy in select patient populations. This symposium will review the pathophysiology and disease burden of RSV infection in the neonatal and pediatric populations as well as highlight proper healthcare practices that can prevent the development of the disease in the NICU or its spread beyond the hospital. Finally, the current pharmacologic symptomatic treatment and disease prevention options will be reviewed. |
|
|
| |
| |
| |
| | Target Audience: |
|
| | This program is intended for medical health professionals involved in the research or care of patients with RSV. |
|
|
| |
| |
| |
| | Objectives: |
|
| | After viewing this program, participants will be able to:- Identify patients at risk for RSV infection
- Recognize the signs and symptoms of RSV disease presentation
- Review integrated approaches and action plans for reducing and preventing the spread of RSV in the hospital and at home
- Compare and contrast existing and emerging pharmacological agents to treat RSV
- Gain an understanding of the risks and benefits of pharmacological options for RSV and its impact on the overall healthcare system
|
|
|
| |
| |
| |
| | Lecturer Biography: |
|
| | Andrea Morris, MSN, RNC, CCRN
Andrea has been in the NICU since 1985. She has done a variety of roles in the NICU from ECMO specialist to educational consultant for Children’s Medical Ventures. She is currently working on her Doctorate of Nursing Practice while also maintaining a full time job as Clinical Nurse Specialist for the 40 bed level 3B NICU at Citrus Valley Medical Center. She has spoken locally and nationally on a variety of neonatal topics.
Leonard E. Weisman, M.D.
Leonard E. Weisman, MD is certified in Pediatrics and Neonatal-Perinatal Medicine by the American Board of Pediatrics and is presently Professor of Pediatrics at Baylor College of Medicine and Director of the Perinatal Center at Texas Children’s Hospital. Prior to his present role at Baylor, Dr. Weisman was Director of the Neonatal-Perinatal Medicine Fellowship at Baylor College of Medicine, Head of the Section of Neonatology at Baylor College of Medicine, and Chief of the Neonatology Service at Texas Children’s Hospital, which is the largest NICU in the United States. Dr. Weisman’s research involves laboratory and clinical studies related to neonatal immunity and infection and he has published over 105 original articles, reviews, books, chapters, letters, and 95 abstracts. Dr. Weisman graduated from the United States Military Academy in 1970 and from Baylor College of Medicine in 1974. After completing a Pediatric Residency in 1977 in Denver, Colorado, he served as a Pediatrician at Keller Army Hospital at West Point, New York for two years. He then completed a Neonatal-Perinatal Medicine Fellowship in Denver, Colorado in 1981 and served as a Neonatologist at Fitzsimons Army Medical Center, Chief of Neonatology at Walter Reed Army Medical Center, Director of the Neonatal-Perinatal Medicine Fellowship and Chief of the Division of Neonatology at the Uniformed Services University, and Consultant in Neonatology to the Surgeon General until 1994 when he retired as a Colonel from active duty service in the United States Army after 24 years and joined the full-time faculty at Baylor College of Medicine.
Dianne S. Charsha, RN, MSN, NNP-BC
Ms. Charsha is presently the Associate Chief Nursing Officer at Cooper University Hospital in Camden, NJ, which is the flagship hospital of the Cooper Health System – an integrated healthcare delivery system that provides a complete range of healthcare services to the citizens of the Delaware Valley. In her role at Cooper University Hospital, Ms. Charsha is responsible for the overall operations and strategic plans for the Med-Surg and Maternal Child Health Departments, the Trauma and Respiratory Therapy Services, and the entire Nursing Administrative team. Her career as a neonatal nurse practitioner has allowed Ms. Charsha to be the Director of a 77+ bed neonatal service and the leader of one of the largest teams of hospital-based neonatal nurse practitioners in the country. Ms. Charsha is a graduate of Wilkes College and earned her graduate nursing degrees at the University of Pennsylvania.
|
|
|
| |
| |
| |
| | Lecturer Disclosure Statement: |
|
| | Total CME and Educational Review Systems have a conflict of interest policy that requires course faculty to disclose any real or apparent commercial financial affiliations related to the content of their presentations and materials. It is not assumed that these financial interests or affiliations will have an adverse impact on the faculty presentations; they are simply noted here to fully inform participants.
Andrea Morris has no relevant financial interests or affiliations with any commercial interests to disclose.
Leonard E. Weisman has a financial interest/relationship or affiliation in the form of:
Dianne S. Charsha, RN, MSN, NNP-BC has no relevant financial interests or affiliations with any commercial interests to disclose. |
|
|
| |
| |
| |
| | Accreditation Statement: |
|
| | Physicians
This activity has been reviewed and is acceptable for up to 1 Prescribed credit hours by the American Academy of Family Physicians. AAFP Prescribed credit is accepted by the AMA as equivalent to AMA PRA Category 1 for The Physician Recognition Award.
Nursing
Educational Review Systems is an approved provider of continuing education in nursing by ASNA, an accredited provider by the ANCC/Commission on Accreditation. Provider # 05-115-08-081. This program is approved for 1.0 hours of continuing education credit.
Educational Review Systems is also approved for nursing continuing education by the state of California and the District of Columbia.
Pharmacists
Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmaceutical education. This program is approved for 1 hours (0.1 CEUs).ACPE # 761-999-08-118-L01-P.
Respiratory Therapists
Respiratory Therapist accreditation expired December 31, 2008.
Accreditation for 2009 is pending. |
|
|
| |
| |
| |
| |
|
|
| |
| |
| |
| |
| |
|
|
|
